<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38372528</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1470-8736</ISSN><JournalIssue CitedMedium="Internet"><Volume>138</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Clinical science (London, England : 1979)</Title><ISOAbbreviation>Clin Sci (Lond)</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and abnormal uterine bleeding: potential associations and mechanisms.</ArticleTitle><Pagination><StartPage>153</StartPage><EndPage>171</EndPage><MedlinePgn>153-171</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1042/CS20220280</ELocationID><Abstract><AbstractText>The impact of COVID-19 on menstruation has received a high level of public and media interest. Despite this, uncertainty exists about the advice that women and people who menstruate should receive in relation to the expected impact of SARS-CoV-2 infection, long COVID or COVID-19 vaccination on menstruation. Furthermore, the mechanisms leading to these reported menstrual changes are poorly understood. This review evaluates the published literature on COVID-19 and its impact on menstrual bleeding, discussing the strengths and limitations of these studies. We present evidence consistent with SARS-CoV-2 infection and long COVID having an association with changes in menstrual bleeding parameters and that the impact of COVID vaccination on menstruation appears less significant. An overview of menstrual physiology and known causes of abnormal uterine bleeding (AUB) is provided before discussing potential mechanisms which may underpin the menstrual disturbance reported with COVID-19, highlighting areas for future scientific study. Finally, consideration is given to the effect that menstruation may have on COVID-19, including the impact of the ovarian sex hormones on acute COVID-19 severity and susceptibility and reported variation in long COVID symptoms across the menstrual cycle. Understanding the current evidence and addressing gaps in our knowledge in this area are essential to inform public health policy, direct the treatment of menstrual disturbance and facilitate development of new therapies, which may reduce the severity of COVID-19 and improve quality of life for those experiencing long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maybin</LastName><ForeName>Jacqueline A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0003-1560-2840</Identifier><AffiliationInfo><Affiliation>Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watters</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowley</LastName><ForeName>Bethan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharp</LastName><ForeName>Gemma C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>School of Psychology, University of Exeter, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvergne</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ISEM, Univ Montpellier, CNRS, IRD, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Anthropology and Museum Ethnography, Oxford, U.K.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Sci (Lond)</MedlineTA><NlmUniqueID>7905731</NlmUniqueID><ISSNLinking>0143-5221</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004717" MajorTopicYN="Y">Endometrium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008598" MajorTopicYN="N">Menstruation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014592" MajorTopicYN="N">Uterine Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008599" MajorTopicYN="N">Menstruation Disturbances</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">Endometrial</Keyword><Keyword MajorTopicYN="N">Endometrium</Keyword><Keyword MajorTopicYN="N">Menses</Keyword><Keyword MajorTopicYN="N">Menstruation</Keyword><Keyword MajorTopicYN="N">Uterus</Keyword></KeywordList><CoiStatement>The authors declare that there are no competing interests associated with the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>20</Day><Hour>11</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38372528</ArticleId><ArticleId IdType="pmc">PMC10876417</ArticleId><ArticleId IdType="doi">10.1042/CS20220280</ArticleId><ArticleId IdType="pii">234074</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sharp G.C., Fraser A., Sawyer G., Kountourides G., Easey K.E., Ford G.et al. . (2022) The COVID-19 pandemic and the menstrual cycle: research gaps and opportunities. Int. J. Epidemiol. 51, 691&#x2013;700 10.1093/ije/dyab239</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab239</ArticleId><ArticleId IdType="pmc">PMC8690231</ArticleId><ArticleId IdType="pubmed">34865021</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Mortazavi J., Hart J.E., Hankins J.A., Katuska L.M., Farland L.V.et al. . (2022) A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristics. Am. J. Obstet. Gynecol. 227, 739e1&#x2013;739e11 10.1016/j.ajog.2022.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2022.07.003</ArticleId><ArticleId IdType="pmc">PMC9277995</ArticleId><ArticleId IdType="pubmed">35841938</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvergne A., Boniface E., Darney B., Shea A., Weber K., Ventola C.et al. . (2024) Associations among menstrual cycle length, coronavirus disease 2019 (COVID-19), and vaccination. Obstet. Gynecol. 143, 83&#x2013;91 10.1097/AOG.0000000000005343</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000005343</ArticleId><ArticleId IdType="pmc">PMC10715707</ArticleId><ArticleId IdType="pubmed">37562052</ArticleId></ArticleIdList></Reference><Reference><Citation>Carp-Veliscu A., Mehedintu C., Frincu F., Bratila E., Rasu S., Iordache I.et al. . (2022) The effects of SARS-CoV-2 infection on female fertility: a review of the literature. Int. J. Environ. Res. Public Health 19, 10.3390/ijerph19020984</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19020984</ArticleId><ArticleId IdType="pmc">PMC8775865</ArticleId><ArticleId IdType="pubmed">35055804</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson T.S., Marions L.B. and Edlund M.G. (2014) Heavy menstrual bleeding significantly affects quality of life. Acta Obstet. Gynecol. Scand. 93, 52&#x2013;57 10.1111/aogs.12292</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aogs.12292</ArticleId><ArticleId IdType="pubmed">24266506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F., Klein S.L. and Levin E.R. (2020) Estradiol, progesterone, immunomodulation, and COVID-19 outcomes. Endocrinology 161, 1&#x2013;8 10.1210/endocr/bqaa127</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa127</ArticleId><ArticleId IdType="pmc">PMC7438701</ArticleId><ArticleId IdType="pubmed">32730568</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack B., von Saltza E., McCorkell L., Santos L., Hultman A., Cohen A.K.et al. . (2023) Female reproductive health impacts of Long COVID and associated illnesses including ME/CFS, POTS, and connective tissue disorders: a literature review. Front Rehabil. Sci. 4, 1122673 10.3389/fresc.2023.1122673</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fresc.2023.1122673</ArticleId><ArticleId IdType="pmc">PMC10208411</ArticleId><ArticleId IdType="pubmed">37234076</ArticleId></ArticleIdList></Reference><Reference><Citation>ACOG Committee Opinion No (2015) 651: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet. Gynecol. 126, e143&#x2013;e146 10.1097/AOG.0000000000001215</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000001215</ArticleId><ArticleId IdType="pubmed">26595586</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Urteaga I., Wiggins C.H., Druet A., Shea A., Vitzthum V.J.et al. . (2020) Characterizing physiological and symptomatic variation in menstrual cycles using self-tracked mobile-health data. NPJ Digit. Med. 3, 79 10.1038/s41746-020-0269-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-0269-8</ArticleId><ArticleId IdType="pmc">PMC7250828</ArticleId><ArticleId IdType="pubmed">32509976</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein S.L. and Flanagan K.L. (2016) Sex differences in immune responses. Nat. Rev. Immunol. 16, 626&#x2013;638 10.1038/nri.2016.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Fang Z., Liu Y., Xing C., Huang L., Mao J.et al. . (2023) Effect of female coronavirus disease 2019 vaccination on assisted reproductive outcomes: a systematic review and meta-analysis. Fertil. Steril. 119, 772&#x2013;783 10.1016/j.fertnstert.2023.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2023.01.024</ArticleId><ArticleId IdType="pmc">PMC9868006</ArticleId><ArticleId IdType="pubmed">36702343</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.C., Everts B., Ivanova Y., O'Sullivan D., Nascimento M., Smith A.M.et al. . (2014) Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 15, 846&#x2013;855 10.1038/ni.2956</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2956</ArticleId><ArticleId IdType="pmc">PMC4139419</ArticleId><ArticleId IdType="pubmed">25086775</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W.et al. . (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270&#x2013;273 10.1038/s41586-020-2012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S.et al. . (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271e8&#x2013;280e8 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro M.G., Critchley H.O.D., Fraser I.S.and Committee FMD (2018) The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int. J. Gynaecol. Obstet. 143, 393&#x2013;408 10.1002/ijgo.12666</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.12666</ArticleId><ArticleId IdType="pubmed">30198563</ArticleId></ArticleIdList></Reference><Reference><Citation>RCOG . (2014) National heavy menstrual bleeding audit: final report</Citation></Reference><Reference><Citation>Critchley H.O.D., Maybin J.A., Armstrong G.M. and Williams A.R.W. (2020) Physiology of the Endometrium and Regulation of Menstruation. Physiol. Rev. 100, 1149&#x2013;1179 10.1152/physrev.00031.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00031.2019</ArticleId><ArticleId IdType="pubmed">32031903</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE  (2007) Clinical Guideline 44. Heavy Menstrual Bleeding http://www.nice.org.uk/nicemedia/pdf/CG44FullGuideline.pdf [1-192]</Citation></Reference><Reference><Citation>Fraser I.S., Mansour D., Breymann C., Hoffman C., Mezzacasa A. and Petraglia F. (2015) Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int. J. Gynaecol. Obstet. 128, 196&#x2013;200 10.1016/j.ijgo.2014.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijgo.2014.09.027</ArticleId><ArticleId IdType="pubmed">25627706</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh E.E., Brocks M.E., Ghant M.S., Recht H.S. and Simon M. (2014) Prevalence and knowledge of heavy menstrual bleeding among African American women. Int. J. Gynaecol. Obstet. 125, 56&#x2013;59 10.1016/j.ijgo.2013.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijgo.2013.09.027</ArticleId><ArticleId IdType="pmc">PMC4017925</ArticleId><ArticleId IdType="pubmed">24486125</ArticleId></ArticleIdList></Reference><Reference><Citation>Prentice A. (1999) Health care implications of dysfunctional uterine bleeding. Bailliere's Best Pract. Res. 13, 181&#x2013;188 10.1053/beog.1999.0016</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/beog.1999.0016</ArticleId><ArticleId IdType="pubmed">10755036</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick K.D., Clark M.A., Steinwachs D.M., Langenberg P., Stovall D., Munro M.G.et al. . (2009) Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment. Womens Health Issues 19, 70&#x2013;78 10.1016/j.whi.2008.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.whi.2008.07.002</ArticleId><ArticleId IdType="pubmed">19111789</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain M. and Sehgal A. (2011) Dengue fever as a cause of menorrhagia. Int. J. Gynaecol. Obstet. 113, 247&#x2013;248 10.1016/j.ijgo.2011.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijgo.2011.01.003</ArticleId><ArticleId IdType="pubmed">21457980</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiwanitkit S. and Wiwanitkit V. (2013) Excessive menstruation bleeding as a presentation of dengue hemorrhagic fever. Arch. Gynecol. Obstet. 287, 1271 10.1007/s00404-012-2657-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-012-2657-z</ArticleId><ArticleId IdType="pubmed">23192626</ArticleId></ArticleIdList></Reference><Reference><Citation>Samal S., Gupta U. and Agarwal P. (2000) Menstrual disorders in genital tuberculosis. J. Indian Med. Assoc. 98, 126&#x2013;127, 9</Citation><ArticleIdList><ArticleId IdType="pubmed">11016169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebar V., Lagana A.S., Chiantera V., Kunic T. and Lukanovic D. (2022) The effect of COVID-19 on the menstrual cycle: a systematic review. J. Clin. Med. 11, 10.3390/jcm11133800</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11133800</ArticleId><ArticleId IdType="pmc">PMC9267255</ArticleId><ArticleId IdType="pubmed">35807090</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Chen G., Hou H., Liao Q., Chen J., Bai H.et al. . (2021) Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod. Biomed. Online 42, 260&#x2013;267 10.1016/j.rbmo.2020.09.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7522626</ArticleId><ArticleId IdType="pubmed">33288478</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh L., Ali A., Aslam I. and Mensah-Djan A. (2021) The effects of SARS-CoV-2 on menstruation. Reprod. Biomed. Online 43, 769 10.1016/j.rbmo.2021.08.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2021.08.014</ArticleId><ArticleId IdType="pmc">PMC8378059</ArticleId><ArticleId IdType="pubmed">34489182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding T., Wang T., Zhang J., Cui P., Chen Z., Zhou S.et al. . (2021) Analysis of Ovarian Injury Associated With COVID-19 Disease in Reproductive-Aged Women in Wuhan, China: An Observational Study. Front. Med. (Lausanne) 8, 635255 10.3389/fmed.2021.635255</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.635255</ArticleId><ArticleId IdType="pmc">PMC8017139</ArticleId><ArticleId IdType="pubmed">33816526</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalfamo C.J., Heslin K.M., Shilen A., Khan S.M., Hunsaker J.R., Austhof E.et al. . (2021) Design of the Arizona CoVHORT: A Population-Based COVID-19 Cohort. Front Public Health 9, 620060 10.3389/fpubh.2021.620060</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.620060</ArticleId><ArticleId IdType="pmc">PMC7902773</ArticleId><ArticleId IdType="pubmed">33643990</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S.M., Shilen A., Heslin K.M., Ishimwe P., Allen A.M., Jacobs E.T.et al. . (2022) SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study. Am. J. Obstet. Gynecol. 226, 270&#x2013;273 10.1016/j.ajog.2021.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.09.016</ArticleId><ArticleId IdType="pmc">PMC8452349</ArticleId><ArticleId IdType="pubmed">34555320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherenack E.M., Salazar A.S., Nogueira N.F., Raccamarich P., Rodriguez V.J., Mantero A.M.et al. . (2022) Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive age. PloS ONE 17, e0276131 10.1371/journal.pone.0276131</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276131</ArticleId><ArticleId IdType="pmc">PMC9604006</ArticleId><ArticleId IdType="pubmed">36288342</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvergne A., Kountourides G., Argentieri M.A., Agyen L., Rogers N., Knight D.et al. . (2023) A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease. iScience 26, 106401 10.1016/j.isci.2023.106401</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106401</ArticleId><ArticleId IdType="pmc">PMC10015085</ArticleId><ArticleId IdType="pubmed">36987520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb A.R. (1913) Experiences with prophylactic typhoid vaccination: its effect on menstruation. Arch. Intern. Med. XII, 565&#x2013;577 10.1001/archinte.1913.00070050082008</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1913.00070050082008</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki S. and Hosono A. (2018) No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study. Papillomavirus Res. 5, 96&#x2013;103 10.1016/j.pvr.2018.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pvr.2018.02.002</ArticleId><ArticleId IdType="pmc">PMC5887012</ArticleId><ArticleId IdType="pubmed">29481964</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong L., Ji H.H., Tang X.W., Pan L.Y., Chen X. and Jia Y.T. (2020) Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: data mining of Vaccine Adverse Event Reporting System. Sci. Rep. 10, 10762 10.1038/s41598-020-67668-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67668-1</ArticleId><ArticleId IdType="pmc">PMC7329819</ArticleId><ArticleId IdType="pubmed">32612121</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingu T., Uchida T., Nishi M., Hayashida K., Kashiwagi S., Hayashi J.et al. . (1982) Menstrual Abnormalities after Hepatitis B Vaccine. Kurume Med. J. 29, 123&#x2013;125 10.2739/kurumemedj.29.123</Citation><ArticleIdList><ArticleId IdType="doi">10.2739/kurumemedj.29.123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gov.UK  (2023) Coronavirus vaccine - summary of Yellow Card reporting. [Available from: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting#annex-1-vaccine-analysis-print</Citation></Reference><Reference><Citation>Edelman A., Boniface E.R., Male V., Cameron S.T., Benhar E., Han L.et al. . (2022) Association between menstrual cycle length and covid-19 vaccination: global, retrospective cohort study of prospectively collected data. BMJ Med. 1, e000297 10.1136/bmjmed-2022-000297</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000297</ArticleId><ArticleId IdType="pmc">PMC9665108</ArticleId><ArticleId IdType="pubmed">36381261</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelman A., Boniface E.R., Benhar E., Han L., Matteson K.A., Favaro C.et al. . (2022) Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination: A U.S.. Cohort. Obstet. Gynecol. 139, 481&#x2013;489</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8936155</ArticleId><ArticleId IdType="pubmed">34991109</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson E.A., Li H., Fruh V., Gabra M., Asokan G., Jukic A.M.Z.et al. . (2022) Covid-19 vaccination and menstrual cycle length in the Apple Women's Health Study. NPJ Digit Med. 5, 165 10.1038/s41746-022-00711-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-022-00711-9</ArticleId><ArticleId IdType="pmc">PMC9628464</ArticleId><ArticleId IdType="pubmed">36323769</ArticleId></ArticleIdList></Reference><Reference><Citation>Trogstad L., Laake I., Robertson A.H., Mjaaland S., Caspersen I.H., Juvet L.K.et al. . (2023) Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination. Vaccine 41, 5271&#x2013;5282 10.1016/j.vaccine.2023.06.088</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.06.088</ArticleId><ArticleId IdType="pubmed">37451876</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvergne A., Woon E.V. and Male V. (2022) Effect of COVID-19 vaccination on the timing and flow of menstrual periods in two cohorts. Front Reprod. Health 4, 952976 10.3389/frph.2022.952976</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/frph.2022.952976</ArticleId><ArticleId IdType="pmc">PMC9580734</ArticleId><ArticleId IdType="pubmed">36303656</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.M.N., Junkins E.J., Luo C., Fatima U.A., Cox M.L. and Clancy K.B.H. (2022) Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination. Sci. Adv. 8, eabm7201 10.1126/sciadv.abm7201</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abm7201</ArticleId><ArticleId IdType="pmc">PMC9286513</ArticleId><ArticleId IdType="pubmed">35857495</ArticleId></ArticleIdList></Reference><Reference><Citation>Darney B.G., Boniface E.R., Van Lamsweerde A., Han L., Matteson K.A., Cameron S.et al. . (2023) Impact of coronavirus disease 2019 (COVID-19) vaccination on menstrual bleeding quantity: An observational cohort study. BJOG 130, 803&#x2013;812 10.1111/1471-0528.17471</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.17471</ArticleId><ArticleId IdType="pubmed">37035899</ArticleId></ArticleIdList></Reference><Reference><Citation>Male V. (2022) COVID-19 vaccination and menstruation. Science 378, 704&#x2013;706 10.1126/science.ade1051</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.ade1051</ArticleId><ArticleId IdType="pubmed">36395209</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Gibson E.A., Jukic A.M.Z., Baird D.D., Wilcox A.J., Curry C.L.et al. . (2023) Menstrual cycle length variation by demographic characteristics from the Apple Women's Health Study. NPJ Digit Med. 6, 100 10.1038/s41746-023-00848-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-023-00848-1</ArticleId><ArticleId IdType="pmc">PMC10226714</ArticleId><ArticleId IdType="pubmed">37248288</ArticleId></ArticleIdList></Reference><Reference><Citation>RCOG B, BGCS  (2020) Joint RCOG, BSGE and BGCS guidance for the management of abnormal uterine bleeding in the evolving Coronavirus (COVID-19) pandemic. Available from: https://www.rcog.org.uk/media/oxyfyvy0/2020-05-21-joint-rcog-bsge-bgcs-guidance-for-management-of-abnormal-ute.pdf [Accessed December 2023]</Citation></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P. and Diaz J.V. (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102&#x2013;e107 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re'em Y.et al. . (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S.et al. . (2021) Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg. Health Eur. 8, 100186 10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina-Perucha L., Lopez-Jimenez T., Holst A.S., Jacques-Avino C., Munros-Feliu J., Martinez-Bueno C.et al. . (2022) Self-Reported Menstrual Alterations During the COVID-19 Syndemic in Spain: A Cross-Sectional Study. Int. J. Womens Health 14, 529&#x2013;544 10.2147/IJWH.S354655</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJWH.S354655</ArticleId><ArticleId IdType="pmc">PMC9013667</ArticleId><ArticleId IdType="pubmed">35444473</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen B.T., Pang R.D., Nelson A.L., Pearson J.T., Benhar Noccioli E., Reissner H.R.et al. . (2021) Detecting variations in ovulation and menstruation during the COVID-19 pandemic, using real-world mobile app data. PloS ONE 16, e0258314 10.1371/journal.pone.0258314</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0258314</ArticleId><ArticleId IdType="pmc">PMC8528316</ArticleId><ArticleId IdType="pubmed">34669726</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamonsen L.A. and Lathbury L.J. (2000) Endometrial leukocytes and menstruation. Hum. Reprod. Update 6, 16&#x2013;27 10.1093/humupd/6.1.16</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/6.1.16</ArticleId><ArticleId IdType="pubmed">10711826</ArticleId></ArticleIdList></Reference><Reference><Citation>Critchley H.O., Jones R.L., Lea R.G., Drudy T.A., Kelly R.W., Williams A.R.et al. . (1999) Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J. Clin. Endocrinol. Metab. 84, 240&#x2013;248 10.1210/jc.84.1.240</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.84.1.240</ArticleId><ArticleId IdType="pubmed">9920091</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R.L., Hannan N.J., Kaitu'u T.J., Zhang J. and Salamonsen L.A. (2004) Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J. Clin. Endocrinol. Metab. 89, 6155&#x2013;6167 10.1210/jc.2004-0507</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2004-0507</ArticleId><ArticleId IdType="pubmed">15579772</ArticleId></ArticleIdList></Reference><Reference><Citation>Marbaix E., Kokorine I., Moulin P., Donnez J., Eeckhout Y. and Courtoy P.J. (1996) Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc. Natl. Acad. Sci. U. S. A. 93, 9120&#x2013;9125 10.1073/pnas.93.17.9120</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.17.9120</ArticleId><ArticleId IdType="pmc">PMC38605</ArticleId><ArticleId IdType="pubmed">8799164</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockwood C.J., Krikun G., Hausknecht V.A., Papp C. and Schatz F. (1998) Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal. Endocrinology 139, 4607&#x2013;4613 10.1210/endo.139.11.6304</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endo.139.11.6304</ArticleId><ArticleId IdType="pubmed">9794472</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamonsen L.A. and Woolley D.E. (1999) Menstruation: induction by matrix metalloproteinases and inflammatory cells. J. Reprod. Immunol. 44, 1&#x2013;27 10.1016/S0165-0378(99)00002-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0378(99)00002-9</ArticleId><ArticleId IdType="pubmed">10530758</ArticleId></ArticleIdList></Reference><Reference><Citation>Garry R., Hart R., Karthigasu K.A. and Burke C. (2009) A re-appraisal of the morphological changes within the endometrium during menstruation: a hysteroscopic, histological and scanning electron microscopic study. Hum. Reprod. 24, 1393&#x2013;1401, dep036 [pii] 10.1093/humrep/dep036</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/dep036</ArticleId><ArticleId IdType="pubmed">19252193</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X., Krieg S., Kuo C.J., Wiegand S.J., Rabinovitch M., Druzin M.L.et al. . (2008) VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. FASEB J. 22, 3571&#x2013;3580 10.1096/fj.08-111401</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.08-111401</ArticleId><ArticleId IdType="pmc">PMC2537439</ArticleId><ArticleId IdType="pubmed">18606863</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousins F.L., Murray A.A., Scanlon J.P. and Saunders P.T. (2016) Hypoxyprobe reveals dynamic spatial and temporal changes in hypoxia in a mouse model of endometrial breakdown and repair. BMC Res. Notes 9, 30 10.1186/s13104-016-1842-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-016-1842-8</ArticleId><ArticleId IdType="pmc">PMC4717617</ArticleId><ArticleId IdType="pubmed">26780953</ArticleId></ArticleIdList></Reference><Reference><Citation>Maybin J.A., Murray A.A., Saunders P.T.K., Hirani N., Carmeliet P. and Critchley H.O.D. (2018) Hypoxia and hypoxia inducible factor-1alpha are required for normal endometrial repair during menstruation. Nat. Commun. 9, 295 10.1038/s41467-017-02375-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02375-6</ArticleId><ArticleId IdType="pmc">PMC5780386</ArticleId><ArticleId IdType="pubmed">29362355</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelety T.J. and Chaudhuri G. (1995) Haemostatic mechanism in the endometrium: role of cyclo-oxygenase products and coagulation factors. Br. J. Pharmacol. 114, 975&#x2013;980 10.1111/j.1476-5381.1995.tb13300.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.1995.tb13300.x</ArticleId><ArticleId IdType="pmc">PMC1510305</ArticleId><ArticleId IdType="pubmed">7780653</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J. and Kadir R.A. (2012) Endometrial haemostasis and menstruation. Rev. Endocr. Metab. Disord. 13, 289&#x2013;299 10.1007/s11154-012-9226-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-012-9226-4</ArticleId><ArticleId IdType="pubmed">23180227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan N.C. and Weitz J.I. (2020) COVID-19 coagulopathy, thrombosis, and bleeding. Blood 136, 381&#x2013;383 10.1182/blood.2020007335</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007335</ArticleId><ArticleId IdType="pmc">PMC7378461</ArticleId><ArticleId IdType="pubmed">32702124</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada H., Shiraki K., Shimpo H., Shimaoka M., Iba T. and Suzuki-Inoue K. (2023) Thrombotic mechanism involving platelet activation, hypercoagulability and hypofibrinolysis in coronavirus disease 2019. Int. J. Mol. Sci. 24, 7975&#x2013;7991 10.3390/ijms24097975</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24097975</ArticleId><ArticleId IdType="pmc">PMC10178520</ArticleId><ArticleId IdType="pubmed">37175680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Cheng Z., Luo L., Zhu Y., Lin W., Ming Z.et al. . (2021) Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis. Thromb. Res. 201, 23&#x2013;29 10.1016/j.thromres.2021.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.02.010</ArticleId><ArticleId IdType="pmc">PMC7886625</ArticleId><ArticleId IdType="pubmed">33631519</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleeson N., Devitt M., Sheppard B.L. and Bonnar J. (1993) Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br. J. Obstet. Gynaecol. 100, 768&#x2013;771 10.1111/j.1471-0528.1993.tb14272.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.1993.tb14272.x</ArticleId><ArticleId IdType="pubmed">8399019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleeson N.C., Buggy F., Sheppard B.L. and Bonnar J. (1994) The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstet. Gynecol. Scand. 73, 274&#x2013;277 10.3109/00016349409023453</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00016349409023453</ArticleId><ArticleId IdType="pubmed">8122512</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar M., Lee C.A., Sabin C.A., Economides D.L. and Kadir R.A. (2004) von Willebrand disease in women with menorrhagia: a systematic review. BJOG 111, 734&#x2013;740 10.1111/j.1471-0528.2004.00176.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2004.00176.x</ArticleId><ArticleId IdType="pubmed">15198765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Z.W., van Wijk X.M.R., Pham H.P. and Marin M.J. (2021) Role of von Willebrand Factor in COVID-19 Associated Coagulopathy. J. Appl. Lab. Med. 6, 1305&#x2013;1315 10.1093/jalm/jfab042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jalm/jfab042</ArticleId><ArticleId IdType="pmc">PMC8135722</ArticleId><ArticleId IdType="pubmed">33930144</ArticleId></ArticleIdList></Reference><Reference><Citation>McDade T.W. (2005) The ecologies of human immune function. Annu. Rev. Anthropol. 34, 495&#x2013;521 10.1146/annurev.anthro.34.081804.120348</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.anthro.34.081804.120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsteen S., Files J.K., Fram T. and Erdmann N. (2023) The role of immune activation and antigen persistence in acute and long COVID. J. Investig. Med. 71, 545&#x2013;562 10.1177/10815589231158041</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10815589231158041</ArticleId><ArticleId IdType="pmc">PMC9996119</ArticleId><ArticleId IdType="pubmed">36879504</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K.et al. . (2022) Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210&#x2013;216 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson H.W., Amo-Addae M., Kenu E., Ilesanmi O.S., Ameme D.K. and Sackey S.O. (2018) Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016. Biomed. Res. Int. 2018, 1909410 10.1155/2018/1909410</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1909410</ArticleId><ArticleId IdType="pmc">PMC6046154</ArticleId><ArticleId IdType="pubmed">30050920</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.Y., Li L., Zhang Y. and Wang X.S. (2020) Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis. Poverty 9, 45 10.1186/s40249-020-00662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G. and van Goor H. (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631&#x2013;637 10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput S.K., Logsdon D.M., Kile B., Engelhorn H.J., Goheen B., Khan S.et al. . (2021) Human eggs, zygotes, and embryos express the receptor angiotensin 1-converting enzyme 2 and transmembrane serine protease 2 protein necessary for severe acute respiratory syndrome coronavirus 2 infection. F S Sci. 2, 33&#x2013;42 10.1016/j.xfss.2020.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xfss.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7831752</ArticleId><ArticleId IdType="pubmed">33521687</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M., Ma L., Xue L., Zhu Q., Zhou S., Dai J.et al. . (2021) Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age. Genomics 113, 3449&#x2013;3460 10.1016/j.ygeno.2021.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2021.08.012</ArticleId><ArticleId IdType="pmc">PMC8372464</ArticleId><ArticleId IdType="pubmed">34418496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ata B., Vermeulen N., Mocanu E., Gianaroli L., Lundin K., Rautakallio-Hokkanen S.et al. . (2023) SARS-CoV-2, fertility and assisted reproduction. Hum. Reprod. Update 29, 177&#x2013;196 10.1093/humupd/dmac037</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/dmac037</ArticleId><ArticleId IdType="pmc">PMC9976972</ArticleId><ArticleId IdType="pubmed">36374645</ArticleId></ArticleIdList></Reference><Reference><Citation>Henarejos-Castillo I., Sebastian-Leon P., Devesa-Peiro A., Pellicer A. and Diaz-Gimeno P. (2020) SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle. Fertil. Steril. 114, 223&#x2013;232 10.1016/j.fertnstert.2020.06.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2020.06.026</ArticleId><ArticleId IdType="pmc">PMC7298504</ArticleId><ArticleId IdType="pubmed">32641214</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilella F., Wang W., Moreno I., Roson B., Quake S.R. and Simon C. (2021) Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium. Hum. Reprod. 36, 2709&#x2013;2719 10.1093/humrep/deab183</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/deab183</ArticleId><ArticleId IdType="pmc">PMC8385818</ArticleId><ArticleId IdType="pubmed">34329437</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousins F.L., Kirkwood P.M., Saunders P.T. and Gibson D.A. (2016) Evidence for a dynamic role for mononuclear phagocytes during endometrial repair and remodelling. Sci. Rep. 6, 36748 10.1038/srep36748</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep36748</ArticleId><ArticleId IdType="pmc">PMC5101509</ArticleId><ArticleId IdType="pubmed">27827431</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott N.A., Mohiyiddeen L., Mariano L.L., Ruane P.T., Aplin J.D., Moran O.C.et al. . (2021) Macrophages in the uterus are functionally specialised and continually replenished from the circulation. bioRxiv 2021.09.02.458731 10.1101/2021.09.02.458731</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.09.02.458731</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miguel-Gomez L., Sebastian-Leon P., Romeu M., Pellicer N., Faus A., Pellicer A.et al. . (2022) Endometrial gene expression differences in women with coronavirus disease 2019. Fertil. Steril. 118, 1159&#x2013;1169 10.1016/j.fertnstert.2022.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2022.09.013</ArticleId><ArticleId IdType="pmc">PMC9624514</ArticleId><ArticleId IdType="pubmed">36333264</ArticleId></ArticleIdList></Reference><Reference><Citation>Henarejos-Castillo I., Devesa-Peiro A., de Miguel-Gomez L., Sebastian-Leon P., Romeu M., Aleman A.et al. . (2022) Predicted COVID-19 molecular effects on endometrium reveal key dysregulated genes and functions. Mol. Hum. Reprod. 28, 10.1093/molehr/gaac035</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molehr/gaac035</ArticleId><ArticleId IdType="pubmed">36205711</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik S., Day K., Perrault I., Charnock-Jones D.S. and Smith S.K. (2006) Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia. Hum. Reprod. 21, 2158&#x2013;2166 10.1093/humrep/del089</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/del089</ArticleId><ArticleId IdType="pubmed">16585124</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith O.P., Jabbour H.N. and Critchley H.O. (2007) Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation. Hum. Reprod. 22, 1450&#x2013;1456 10.1093/humrep/del503</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/del503</ArticleId><ArticleId IdType="pmc">PMC2694303</ArticleId><ArticleId IdType="pubmed">17264103</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.K., Abel M.H., Kelly R.W. and Baird D.T. (1981) Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br. J. Obstet. Gynaecol. 88, 434&#x2013;442 10.1111/j.1471-0528.1981.tb01009.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.1981.tb01009.x</ArticleId><ArticleId IdType="pubmed">7225303</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.K., Abel M.H., Kelly R.W. and Baird D.T. (1981) A role for prostacyclin (PGi2) in excessive menstrual bleeding. Lancet 1, 522&#x2013;524 10.1016/S0140-6736(81)92862-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(81)92862-2</ArticleId><ArticleId IdType="pubmed">6111633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bofill Rodriguez M., Lethaby A. and Farquhar C. (2019) Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst. Rev. 9, CD000400 10.1002/14651858.CD000400.pub4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000400.pub4</ArticleId><ArticleId IdType="pmc">PMC6751587</ArticleId><ArticleId IdType="pubmed">31535715</ArticleId></ArticleIdList></Reference><Reference><Citation>Junqueira C., Crespo &#xc2;., Ranjbar S., de Lacerda L.B., Lewandrowski M., Ingber J.et al. . (2022) Fc&#x3b3;R-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606, 576&#x2013;584 10.1038/s41586-022-04702-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04702-4</ArticleId><ArticleId IdType="pmc">PMC10071495</ArticleId><ArticleId IdType="pubmed">35385861</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rooij L., Becker L.M. and Carmeliet P. (2022) A role for the vascular endothelium in post-acute COVID-19? Circulation 145, 1503&#x2013;1505 10.1161/CIRCULATIONAHA.122.059231</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059231</ArticleId><ArticleId IdType="pubmed">35576316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., Calcaterra I.L., Mosella M., Formisano R., D'Anna S.E., Bachetti T.et al. . (2022) Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target. Biomedicines 10, 812&#x2013;828 10.3390/biomedicines10040812</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040812</ArticleId><ArticleId IdType="pmc">PMC9029464</ArticleId><ArticleId IdType="pubmed">35453563</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R., Enjyoji K. and Schmaier A.A. (2022) Vasculopathy in COVID-19. Blood 140, 222&#x2013;235 10.1182/blood.2021012250</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012250</ArticleId><ArticleId IdType="pmc">PMC8736280</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId></ArticleIdList></Reference><Reference><Citation>Basta G. (2021) Direct or indirect endothelial damage? An unresolved question EBioMedicine 64, 103215 10.1016/j.ebiom.2021.103215</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103215</ArticleId><ArticleId IdType="pmc">PMC7823198</ArticleId><ArticleId IdType="pubmed">33493794</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S.W., Ilyas I. and Weng J.P. (2023) Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol. Sin. 44, 695&#x2013;709 10.1038/s41401-022-00998-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin M.R. (2022) Insights into Endotheliopathy in COVID-19. Am. J. Respir. Crit. Care Med. 206, 926&#x2013;928 10.1164/rccm.202207-1258ED</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202207-1258ED</ArticleId><ArticleId IdType="pmc">PMC9801991</ArticleId><ArticleId IdType="pubmed">35819867</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I., Fonseca-Rodriguez O., Farrington P., Lindmark K. and Connolly A.M.F. (2021) Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet 398, 599&#x2013;607 10.1016/S0140-6736(21)00896-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00896-5</ArticleId><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>Markee J.E. (1940) Menstruation in intraocular endometrial transplants in the rhesus monkey. Contributions to Embryol. 177, 220&#x2013;230</Citation></Reference><Reference><Citation>Baird D.T., Cameron S.T., Critchley H.O., Drudy T.A., Howe A., Jones R.L.et al. . (1996) Prostaglandins and menstruation. Eur. J. Obstet. Gynecol. Reprod. Biol. 70, 15&#x2013;17 10.1016/S0301-2115(96)02568-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-2115(96)02568-7</ArticleId><ArticleId IdType="pubmed">9031912</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh M.M., Malakooti N., Taylor N.H., Findlay J.K. and Salamonsen L.A. (1997) Endothelin and neutral endopeptidase in the endometrium of women with menorrhagia. Hum. Reprod. 12, 2036&#x2013;2040 10.1093/humrep/12.9.2036</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/12.9.2036</ArticleId><ArticleId IdType="pubmed">9363725</ArticleId></ArticleIdList></Reference><Reference><Citation>Mints M., Hultenby K., Zetterberg E., Blomgren B., Falconer C., Rogers R.et al. . (2007) Wall discontinuities and increased expression of vascular endothelial growth factor-A and vascular endothelial growth factor receptors 1 and 2 in endometrial blood vessels of women with menorrhagia. Fertil. Steril. 88, 691&#x2013;697, S0015-0282(06)04735-2 [pii] 10.1016/j.fertnstert.2006.11.190</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2006.11.190</ArticleId><ArticleId IdType="pubmed">17336974</ArticleId></ArticleIdList></Reference><Reference><Citation>Abberton K.M., Taylor N.H., Healy D.L. and Rogers P.A. (1999) Vascular smooth muscle cell proliferation in arterioles of the human endometrium. Hum. Reprod. 14, 1072&#x2013;1079 10.1093/humrep/14.4.1072</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/14.4.1072</ArticleId><ArticleId IdType="pubmed">10221243</ArticleId></ArticleIdList></Reference><Reference><Citation>Abberton K.M., Healy D.L. and Rogers P.A. (1999) Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles. Hum. Reprod. 14, 3095&#x2013;3100 10.1093/humrep/14.12.3095</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/14.12.3095</ArticleId><ArticleId IdType="pubmed">10601102</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. (2020) The mystery of the pandemic's &#x2018;happy hypoxia&#x2019;. Science 368, 455&#x2013;456 10.1126/science.368.6490.455</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.368.6490.455</ArticleId><ArticleId IdType="pubmed">32355007</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux C.A. and Lagier J.C. (2023) Unraveling the Underlying Molecular Mechanism of &#x2018;Silent Hypoxia&#x2019; in COVID-19 Patients Suggests a Central Role for Angiotensin II Modulation of the AT1R-Hypoxia-Inducible Factor Signaling Pathway. J. Clin. Med. 12, 2445&#x2013;2465 10.3390/jcm12062445</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12062445</ArticleId><ArticleId IdType="pmc">PMC10056466</ArticleId><ArticleId IdType="pubmed">36983445</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz D.A., Avvad-Portari E., Babal P., Baldewijns M., Blomberg M., Bouachba A.et al. . (2022) Placental Tissue Destruction and Insufficiency From COVID-19 Causes Stillbirth and Neonatal Death From Hypoxic-Ischemic Injury. Arch. Pathol. Lab. Med. 146, 660&#x2013;676 10.5858/arpa.2022-0029-SA</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2022-0029-SA</ArticleId><ArticleId IdType="pubmed">35142798</ArticleId></ArticleIdList></Reference><Reference><Citation>, Group RC Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L.et al. . (2021) Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med. 384, 693&#x2013;704 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Rae M., Mohamad A., Price D., Hadoke P.W., Walker B.R., Mason J.I.et al. . (2009) Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation. J. Clin. Endocrinol. Metab. 94, 1443&#x2013;1450 10.1210/jc.2008-1879</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2008-1879</ArticleId><ArticleId IdType="pubmed">19158196</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain V., Chodankar R.R., Maybin J.A. and Critchley H.O.D. (2022) Uterine bleeding: how understanding endometrial physiology underpins menstrual health. Nat. Rev. Endocrinol. 18, 290&#x2013;308 10.1038/s41574-021-00629-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-021-00629-4</ArticleId><ArticleId IdType="pmc">PMC9098793</ArticleId><ArticleId IdType="pubmed">35136207</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner P., Whitaker L.H.R., Parker R.A., Weir C.J., Douglas A., Hansen C.H.et al. . (2021) Low dose dexamethasone as treatment for women with heavy menstrual bleeding: A response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM). EBioMedicine 69, 103434 10.1016/j.ebiom.2021.103434</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103434</ArticleId><ArticleId IdType="pmc">PMC8261537</ArticleId><ArticleId IdType="pubmed">34218053</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T., Gonevski M., Clark C., Baitule S., Sharma K., Magar A.et al. . (2021) Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin. Med. (Lond.) 21, e629&#x2013;e632 10.7861/clinmed.2021-0462</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S., Catalogna M., Sasson E., Elman-Shina K., Hadanny A., Lang E.et al. . (2022) Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci. Rep. 12, 11252 10.1038/s41598-022-15565-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjellberg A., Abdel-Halim L., Hassler A., El Gharbi S., Al-Ezerjawi S., Bostrom E.et al. . (2022) Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial. BMJ Open 12, e061870 10.1136/bmjopen-2022-061870</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-061870</ArticleId><ArticleId IdType="pmc">PMC9638753</ArticleId><ArticleId IdType="pubmed">36323462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadanny A. and Efrati S. (2020) The hyperoxic-hypoxic paradox. Biomolecules 10, 958&#x2013;976 10.3390/biom10060958</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10060958</ArticleId><ArticleId IdType="pmc">PMC7355982</ArticleId><ArticleId IdType="pubmed">32630465</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimino F., Balestra C., Germonpre P., De Bels D., Tillmans F., Saija A.et al. . (1985) Pulsed high oxygen induces a hypoxic-like response in human umbilical endothelial cells and in humans. J. Appl. Physiol. 113, 1684&#x2013;1689, 2012 10.1152/japplphysiol.00922.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00922.2012</ArticleId><ArticleId IdType="pubmed">23042909</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanez N.D., Weiss N.S., Romand J.A. and Treggiari M.M. (2020) COVID-19 mortality risk for older men and women. BMC Public Health 20, 1742 10.1186/s12889-020-09826-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-09826-8</ArticleId><ArticleId IdType="pmc">PMC7675386</ArticleId><ArticleId IdType="pubmed">33213391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sund M., Fonseca-Rodriguez O., Josefsson A., Welen K. and Fors Connolly A.M. (2022) Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study. BMJ Open 12, e053032 10.1136/bmjopen-2021-053032</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-053032</ArticleId><ArticleId IdType="pmc">PMC8844968</ArticleId><ArticleId IdType="pubmed">35165090</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeland U., Coluzzi F., Simmaco M., Mura C., Bourne P.E., Heiland M.et al. . (2020) Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med. 18, 369 10.1186/s12916-020-01851-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01851-z</ArticleId><ArticleId IdType="pmc">PMC7685778</ArticleId><ArticleId IdType="pubmed">33234138</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterworth M., McClellan B. and Allansmith M. (1967) Influence of sex in immunoglobulin levels. Nature 214, 1224&#x2013;1225 10.1038/2141224a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/2141224a0</ArticleId><ArticleId IdType="pubmed">4169229</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson D.P., Hall O.J., Nilles T.L., Bream J.H. and Klein S.L. (2014) 17beta-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs. J. Virol. 88, 4711&#x2013;4720 10.1128/JVI.02081-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02081-13</ArticleId><ArticleId IdType="pmc">PMC3993800</ArticleId><ArticleId IdType="pubmed">24522912</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson D.P., Lorenzo M.E., Jian W. and Klein S.L. (2011) Elevated 17beta-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses. PLoS Pathog. 7, e1002149 10.1371/journal.ppat.1002149</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002149</ArticleId><ArticleId IdType="pmc">PMC3145801</ArticleId><ArticleId IdType="pubmed">21829352</ArticleId></ArticleIdList></Reference><Reference><Citation>Speyer C.L., Rancilio N.J., McClintock S.D., Crawford J.D., Gao H., Sarma J.V.et al. . (2005) Regulatory effects of estrogen on acute lung inflammation in mice. Am. J. Physiol. Cell Physiol. 288, C881&#x2013;C890 10.1152/ajpcell.00467.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00467.2004</ArticleId><ArticleId IdType="pubmed">15761213</ArticleId></ArticleIdList></Reference><Reference><Citation>Haitao T., Vermunt J.V., Abeykoon J., Ghamrawi R., Gunaratne M., Jayachandran M.et al. . (2020) COVID-19 and sex differences: mechanisms and biomarkers. Mayo Clin. Proc. 95, 2189&#x2013;2203 10.1016/j.mayocp.2020.07.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.07.024</ArticleId><ArticleId IdType="pmc">PMC7402208</ArticleId><ArticleId IdType="pubmed">33012349</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S., Newson L., Briggs T.A., Grammatopoulos D., Young L. and Gill P. (2021) Long COVID risk - a signal to address sex hormones and women's health. Lancet Reg. Health Eur. 11, 100242 10.1016/j.lanepe.2021.100242</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q., VanGundy T.B., Shibata S., Auchus R.J., Williams G.H. and Levine B.D. (2010) Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome. Hypertension 56, 82&#x2013;90 10.1161/HYPERTENSIONAHA.110.151787</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.110.151787</ArticleId><ArticleId IdType="pmc">PMC2894615</ArticleId><ArticleId IdType="pubmed">20479333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>